Zhangzhou Pientzehuang Pharmaceutical | 600436 - Selling And Administration Expenses


Zz Pientze Pharmaceu reported CNY267.85M in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Akebia Therapeutics USD 23.53M 3.19M Dec/2025
Alaunos Therapeutics USD 424K 23K Jun/2026
Avita Medical AUD 19.54M 516K Jun/2026
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Dianthus Therapeutics USD 13.56M 1.09M Jun/2026
Ionis Pharmaceuticals USD 154M 23.92M Sep/2026
IQVIA Holdings USD 569M 5M Sep/2026
Jiangsu Hengrui CNY 2.93B 143.13M Sep/2026
Kangmei Pharma CNY 253.72M 16.66M Jun/2026
Moderna USD 282M 66M Sep/2026
Revvity USD 275.33M 3.25M Sep/2026
Sh Fosun Pharma CNY 3.07B 276.55M Sep/2026
Tectonic Therapeutic USD 6.17M 260K Jun/2026
Viatris USD 950.8M 183.7M Sep/2026
Wuxi Apptec CNY 1.25B 263.98M Sep/2026
Xeris Pharmaceuticals USD 61.04M 7.89M Jun/2026
Zz Pientze Pharmaceu CNY 267.85M 44.71M Sep/2026